Cellectar, Inc   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Madison WI United States (2002)

Organization Overview

First Clinical Trial
2004
NCT00582283
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Cellectar | Cellectar Biosciences, Inc. | Cellectar, Inc